Healthcare Deal Killers: Red Flags That Should Make You Walk Away

About this course

A healthcare acquisition can look attractive on paper while hiding risks that may not surface until months—or even years—after closing. This episode examines the warning signs that can derail a deal, including government investigations, compliance exposure, weak revenue-cycle performance, outdated technology, and the potential loss of key physicians. Learn why standard M&A diligence may not be enough in healthcare and what CPAs and risk professionals should assess before recommending, repricing, or walking away from a transaction.

What you'll learn

Upon completion of this course, you will be able to:

• Explain why healthcare acquisitions require specialized due diligence beyond traditional financial analysis.
• Identify common financial, operational, compliance, cybersecurity, and technology risks that can negatively impact healthcare transactions.
• Assess how revenue cycle performance, regulatory exposure, and operational dependencies can create hidden liabilities for acquiring organizations.
• Recognize the role CPAs and risk professionals play in evaluating healthcare transaction risks.
• Evaluate strategies organizations can use to identify, mitigate, and monitor risks before completing a healthcare acquisition.

Quizzes and assessment

Complete all quizzes and the final assessment to earn CPE.

Quizzes open automatically at the markers in your audio.